Recent Security Class Actions

GRAIL Inc. Common Stock (NASDAQ: GRAL)

4 Days left to seek lead plaintiff status.

Company Name:GRAIL Inc. Common Stock
Stock Symbol:NASDAQ: GRAL
Class Period Start:05/13/2025
Class Period End (inclusive):02/19/2026
Filing Deadline:08/04/2026

The Complaint alleges that Defendants provided investors with material information concerning the likelihood of success of Grail’s NHS-Galleri trial achieving its primary endpoint of a statistically significant reduction in Stage III & IV cancers. Defendants’ statements included, among other things, confidence in the success of Galleri, consistently promoting its effectiveness “in the real world” and the positive predictive value (“PPV”) observed in the Pathfinder studies and in NHS-Galleri’s top-line results as sources of confidence for its potential. Defendants further routinely touted the design of the NHS-Galleri and how three years were necessary to demonstrate the achievability of the primary endpoint.   

GRAIL Inc. Common Stock (NASDAQ: GRAL) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address